| Literature DB >> 26118924 |
Qian Chen1, Shun Xiao1, Zhenhao Li1, Ni Ai1, Xiaohui Fan1.
Abstract
Along with an indispensable role in healthcare system of China for centuries, Traditional Chinese Medicine (TCM) shows increasing usages as complementary therapy in western countries. To improve our understanding on their therapeutic effects, it's critical to unveil chemical compositions of TCM formula, the predominant form of therapy in TCM. However, intrinsic chemical complexity makes it a challenging task to perform analysis on each individual TCM formula even with most current state-of-art analytic techniques available. In this work we approached this question by focusing on analogous formulae, a unique category of TCM formulae grouped together based on shared herbs and/or similar TCM syndromes. Systematic chemical profiling on five Si-Ni decoctions (SNs) for cardiovascular diseases was performed by multistage MS and high-resolution MS (HR-MS) experiments. A total of 83 compounds, including alkaloids, flavonoids, ginsenosides, bile acids and triterpenoids, were described. Analysis on SNs-treated rats detected 55 prototype compounds and 39 metabolites in the systemic circulation in vivo, which may contribute directly to their observed clinical efficacies. This approach offers great advantage to speed up identification of chemical compositions of formula and reveal the difference among these analogous formulae that may be related to diverse clinical effects.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26118924 PMCID: PMC4484491 DOI: 10.1038/srep11638
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Comparative analysis scheme of Si-Ni decoction analogous formulae in vitro and in vivo.
Figure 2The negative base peak MS spectrum
(a), positive base peak MS spectrum (b) and PDA spectrum (c) of FSIN.
Figure 3The proposed fragmentation pathways of 14-hydroxy-2-isobutyrylhetisine N-oxide
(a), schaftoside (b) and Licorice saponin A3 (c and d).
Composition of Si-Ni Decoction Analogous Formulae.
| Traditional Chinese Medicinal Materials (g) | Si-Ni Decoction Analogous Formulae | ||||
|---|---|---|---|---|---|
| SIN | RSIN | TSIN | ZSIN | FSIN | |
| 31.2 | 31.2 | 31.2 | 31.2 | 15.6 | |
| 23.4 | 23.4 | 46.8 | 46.8 | 11.7 | |
| 25 | 25 | 30 | 30 | 12.5 | |
| 15.6 | 7.8 | ||||
| 31.2 | |||||
| 6 | |||||
Compounds identified from Si-Ni decoction analogous formulae in vitro and in vivo.
Figure 4Chemical structures of prototype compounds in dosed plasma.
Metabolic profiling of Si-Ni decoction analogous formulae in rat plasma.
| No. | Rt | Formula | Metabolic pathway | Error (ppm) | Prototype | Group | Fold change of intensity |
|---|---|---|---|---|---|---|---|
| M1 | 14.26 | C22H35O5N | Demethylation | 0.7 | Isotalatizidine | G1 | 15.10 |
| Deethylation | Talatizamine | ||||||
| M2 | 15.11 | C20H23O3N | Alcohol to ketone | 0.2 | Hetisinone | G2 | 5.70 |
| Loss of O | Fuzitine | ||||||
| Alcohols dehydration | Delbidine | ||||||
| M3 | 18.15 | C22H31O6N | Hydrolysis | 0.3 | Guan fu base Y | G1 | 7.73 |
| M4 | 19.75 | C24H37O6N | Hydroxylation + desaturation | 0.9 | Talatizamine | G1 | 8.67 |
| Alcohol to ketone | Neoline | ||||||
| Demethylation | Coldephnine | ||||||
| Deethylation | 14-acetyl-8- | ||||||
| M5 | 28.94 | C26H33O8N | Hydroxylation | 0.5 | Guan fu base G | G1 | 25.48 |
| M6 | 29.29 | C26H33O9N | 2 × hydroxylation | −0.1 | Guan fu base G | G1 | 5.12 |
| M7 | 29.57 | C25H37O6N | Alcohol to ketone | 0.8 | Coldephnine | G2 | 13.46 |
| M8 | 33.30 | C25H39O5N | Loss of O | −0.8 | Coldephnine | G1 | 5.09 |
| Hydroxymethylene loss | 14-acetyl-8- | ||||||
| M9 | 34.99 | C15H10O5 | Hydroxylation + desaturation | 0.4 | Liquiritigenin | G2 | 30.23 |
| M10 | 39.64 | C22H20O11 | Demethylation to carboxylic acid | 0.5 | Ononin | G1 | 9.48 |
| M11 | 40.63 | C28H37O8N | Hydroxylation | 0.3 | Ouvrardiantine A | G1 | 16.77 |
| M12 | 41.18 | C26H30O12 | Loss of O | 4.9 | Liquiritin apioside isomer | G1 | 34.68 |
| Loss of O | Liquiritin apioside | ||||||
| Loss of O | Isoliquiritin apioside | ||||||
| Loss of O | Isoliquiritin apioside isomer | ||||||
| M13 | 42.06 | C26H33O6N | Alcohol to ketone | −0.1 | Guan fu base F | G1 | 8.78 |
| Loss of O | Guan fu base G | ||||||
| M14 | 42.20 | C15H12O5 | Hydroxylation | 0.8 | Liquiritigenin | G1 | 4.98 |
| M15 | 42.20 | C21H20O11 | Hydroxylation + glucuronide conjugation | 0.2 | Liquiritigenin | G1 | 43.90 |
| Demethylation + 2 × hydroxylation | Ononin | ||||||
| M16 | 42.55 | C22H22O11 | 2 × hydroxylation | 0.4 | Ononin | G1 | 83.02 |
| M17 | 42.56 | C16H14O5 | Hydroxylation +methylation | 0.7 | Liquiritigenin | G1 | 27.74 |
| M18 | 43.27 | C27H35O7N | Demethylation | 0.8 | Ouvrardiantine A | G1 | 11.40 |
| Methylation | Guan fu base G | ||||||
| Acetylation | Racemulosine A | ||||||
| M19 | 44.36 | C15H12O7S | Sulfate conjugation | 1.0 | Liquiritigenin | G2 | 21.13 |
| M20 | 47.13 | C22H20O10 | Hydroxylation + desaturation | 0.5 | Ononin | G1 | 13.79 |
| M21 | 49.07 | C21H20O10 | Hydroxylation + desaturation | 0.7 | Liquiritin isomer | G1 | 80.87 |
| Hydroxylation + desaturation | Liquiritin | ||||||
| Hydroxylation + desaturation | Isoliquiritin | ||||||
| Glucuronide conjugation | Liquiritigenin | ||||||
| M22 | 50.71 | C15H10O4 | Alcohol to ketone | 0.4 | Liquiritigenin | G1 | 8.22 |
| M23 | 50.79 | C17H14O5 | Acetylation | 0.8 | Liquiritigenin | G2 | 7.72 |
| M24 | 54.90 | C34H42O19 | Acetylation | 4.3 | Glucoisoliquiritin apioside | G2 | 33.37 |
| M25 | 55.67 | C28H37O12N | Hydroxylation + glucuronide conjugation | 4.7 | Guan fu base Y | G1 | 7.54 |
| M26 | 55.95 | C22H22O10 | hydroxylation | −0.8 | Ononin | G1 | 22.37 |
| M27 | 56.00 | C16H14O4 | Methylation | 0.6 | Liquiritigenin | G1 | 10.21 |
| M28 | 56.42 | C32H51O11N | Glucuronide conjugation | −0.9 | Glycohyodeoxycholic acid | G2 | 15.58 |
| Glucuronide conjugation | Glycochenodeoxycholic acid | ||||||
| M29 | 65.44 | C26H41O4N | Alcohols dehydration | 0.6 | Glycohyodeoxycholic acid | G2 | 11.65 |
| Alcohols dehydration | Glycochenodeoxycholic acid | ||||||
| M30 | 69.09 | C26H41O5N | Alcohol to ketone | 0.8 | Glycohyodeoxycholic acid | G1 | 8.82 |
| Alcohol to ketone | Glycochenodeoxycholic acid | ||||||
| Alcohols dehydration | Glycohyocholic acid | ||||||
| M31 | 70.91 | C50H77O22N | Glycine conjugation | 2.9 | Yunganoside G1 | G2 | 8.21 |
| Taurine conjugation | Yunganoside J1 or L1 | ||||||
| M32 | 72.90 | C23H32O10 | Hydroxylation + glucuronide conjugation | −2.2 | 6-Shogaol | G2 | 7.92 |
| M33 | 74.64 | C31H47O13N | Hydroxylation + glucuronide conjugation | 0.4 | Coldephnine | G2 | 11.76 |
| M34 | 75.56 | C26H43O5NS | Alcohols dehydration | −0.9 | Taurohyodeoxycholic acid | G1 | 17.01 |
| Alcohols dehydration | Taurochenodeoxycholic acid | ||||||
| M35 | 76.37 | C28H45O6N | Acetylation | −0.6 | Glycohyodeoxycholic acid | G2 | 12.57 |
| Acetylation | Glycochenodeoxycholic acid | ||||||
| M36 | 80.29 | C30H48O5 | Hydrolysis | −3.3 | Glycyrrhizic acid aglycone isomer | G2 | 5.04 |
| Hydrolysis | Glycyrrhizic acid aglycone | ||||||
| M37 | 80.43 | C31H46O5 | Hydroxylation + methylation | −0.8 | Uralenolide | G2 | 6.87 |
| M38 | 81.14 | C31H48O5 | Hydroxylation + methylation | 0.7 | Glycyrrhizic acid aglycone isomer | G2 | 6.68 |
| Hydroxylation + methylation | Glycyrrhizic acid aglycone | ||||||
| M39 | 83.58 | C31H48O4 | Methylation | −2.2 | Glycyrrhizic acid aglycone isomer | G2 | 12.38 |
| Methylation | Glycyrrhizic acid aglycone |
aThe retention time of FSIN were used as a standard one; the retention time of those peaks that were not appeared in FSIN were from the ZSIN.
bThe retention time in positive base peak of high resolution mass spectrum.
The oral single-dose of SNs treated to rats for analysis in vivo.
| Si-Ni Decoction Analogous Formulae | Daily Dosage | Oral Single-dose |
|---|---|---|
| SIN | 7.2 | 57.3 |
| RSIN | 8.6 | 68.5 |
| TSIN | 9.7 | 77.8 |
| ZSIN | 10.6 | 85.0 |
| FSIN | 7.1 | 56.7 |
aDaily dosage means the dosage for per kilogram body weight rat every day. It was translated from a human equivalent dose taking into account body weight and body surface area.
bOral single-dose is the actual dosage in our animal experiment. Based on the maximal oral dosage and the solubility of SNs, the oral single-dose of SNs was 3.2 mL per 100 g body weight (i.e. 8 times daily dosage).
The mainly metabolism pathway of xenobiotics and the formula change relative to the parent compound.
| Metabolic pathway | Formula change of the parent compound | Metabolic pathway | Formula change of the parent compound |
|---|---|---|---|
| Decarboxylation | –COOH | Demethylation + hydroxylation | −CH2 + O |
| Hydrolysis | +H2O | Deethylation | −C2H4 |
| Hydroxylation | +O | Isopropyl dealkylation | −C3H6 |
| Demethylation + 2 × hydroxylation | −CH2 + O2 | Methylation | +CH2 |
| Reduction | +H2 | Acetylation | +C2H2O |
| Hydroxylation + desaturation | +O−H2 | S-cysteine conjugation | +C3H5NO2S |
| Alcohol to ketone | −H2 | Glycine conjugation | +C2H3NO |
| Demethylation | −CH2 | Taurine conjugation | +C2H5NO2S |
| Hydroxymethylene loss | −CH2O | Cysteine conjugation | +C3H5NOS |
| Loss of O | −O | Glucuronide conjugation | +C6H8O6 |
| 2 × hydroxylation | +O2 | Hydroxylation + glucuronide conjugation | +C6H8O7 |
| Demethylation to carboxylic acid | −CH2 + CO2 | Sulfate conjugation | +SO3 |
| Alcohols dehydration | −H2O | Hydroxylation + sulfation | +SO4 |
| Hydroxylation + methylation | +O + CH2 | Decarboxylation + glucuronidation | −CO + C6H8O6 |